Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Bagel

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Journal of Drugs in Dermatology : JDD|April 10, 2020
Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With ApremilastJerry Bagel, Bradley S Stolshek, Yue Yang, et al.
Journal of Drugs in Dermatology : JDD|July 27, 2006
Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: results from an open-label, multicenter studyJohn Y M Koo, Jerry Bagel, Marianne T Sweetser, et al.
Journal of the American Academy of Dermatology|March 25, 2011
A review of phototherapy protocols for psoriasis treatmentWhitney Lapolla, Brad A Yentzer, Jerry Bagel, et al.
Journal of Drugs in Dermatology : JDD|December 27, 2018
Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque PsoriasisLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.
The British Journal of Dermatology|October 15, 2025
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis over 5 years in patients living with obesityMark G Lebwohl, Andrew Blauvelt, Jerry Bagel, et al.
International Journal of Dermatology|March 26, 2003
Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacyNick J Lowe, John Gonzalez, Jerry Bagel, et al.
Journal of the American Academy of Dermatology|February 3, 2020
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trialDavid M Pariser, Jerry Bagel, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|February 8, 2022
Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With PsoriasisJerry Bagel, Daljit Tatla, Scarlett Hellot, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2Kristina C Duffin, Kim A Papp, Jerry Bagel, et al.
The Journal of Dermatological Treatment|October 8, 2015
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II studyJohn Koo, Stephen Tyring, William P Werschler, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Drugs in Dermatology : JDD|April 10, 2020
Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With ApremilastJerry Bagel, Bradley S Stolshek, Yue Yang, et al.
Journal of Drugs in Dermatology : JDD|July 27, 2006
Alefacept in combination with ultraviolet B phototherapy for the treatment of chronic plaque psoriasis: results from an open-label, multicenter studyJohn Y M Koo, Jerry Bagel, Marianne T Sweetser, et al.
Journal of the American Academy of Dermatology|March 25, 2011
A review of phototherapy protocols for psoriasis treatmentWhitney Lapolla, Brad A Yentzer, Jerry Bagel, et al.
Journal of Drugs in Dermatology : JDD|December 27, 2018
Halobetasol and Tazarotene: Further Defining the Role of a Unique Fixed Combination Topical Lotion in Moderate-to-Severe Plaque PsoriasisLinda Stein Gold, Jerry Bagel, Mark Lebwohl, et al.
The British Journal of Dermatology|October 15, 2025
Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis over 5 years in patients living with obesityMark G Lebwohl, Andrew Blauvelt, Jerry Bagel, et al.
International Journal of Dermatology|March 26, 2003
Repeat courses of intravenous alefacept in patients with chronic plaque psoriasis provide consistent safety and efficacyNick J Lowe, John Gonzalez, Jerry Bagel, et al.
Journal of the American Academy of Dermatology|February 3, 2020
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trialDavid M Pariser, Jerry Bagel, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|February 8, 2022
Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With PsoriasisJerry Bagel, Daljit Tatla, Scarlett Hellot, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2Kristina C Duffin, Kim A Papp, Jerry Bagel, et al.
The Journal of Dermatological Treatment|October 8, 2015
Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II studyJohn Koo, Stephen Tyring, William P Werschler, et al.
Pageof 10